Free Trial
ASX:IVR

Investigator Resources (IVR) Stock Price, News & Analysis

Investigator Resources logo

About Investigator Resources Stock (ASX:IVR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.78 million shs
Average Volume
N/A
Market Capitalization
A$41.31 million
P/E Ratio
N/A
Dividend Yield
12.77%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Investigator Resources and its competitors with MarketBeat's FREE daily newsletter.

IVR Stock News Headlines

[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Investigator Resources Director Increases Stake
See More Headlines

IVR Stock Analysis - Frequently Asked Questions

Investigator Resources Limited (ASX:IVR) posted its quarterly earnings results on Tuesday, August, 28th. The company reported $0.00 earnings per share (EPS) for the quarter. Investigator Resources had a negative net margin of 14,540.51% and a negative trailing twelve-month return on equity of 5.87%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Investigator Resources investors own include McEwen Mining (MUX), McEwen (MUX), Silver Mines (SVL), U.S. GoldMining (USGO), Teck Resources (TECK), Takeda Pharmaceutical (TAK) and Orchid Island Capital (ORC).

Company Calendar

Last Earnings
8/28/2018
Today
7/25/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Other Industrial Metals & Mining
Sub-Industry
Trading
Current Symbol
ASX:IVR
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$1.98 million
Net Margins
-14,540.51%
Pretax Margin
N/A
Return on Equity
-5.87%
Return on Assets
-3.98%

Debt

Debt-to-Equity Ratio
0.35
Current Ratio
3.08
Quick Ratio
4.41

Sales & Book Value

Annual Sales
A$234.28 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
2.40
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,590,000,000
Free Float
N/A
Market Cap
A$41.31 million
Optionable
Not Optionable
Beta
1.80
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (ASX:IVR) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners